stockrowDENTSPLY SIRONA Inc.
XRAY Healthcare Medical Instruments & Supplies
DENTSPLY SIRONA Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.7 billion, down 2.98% from fiscal 2024.
- Revenue
- −7.52%
- EPS
- +99.5%
- Free cash flow
- −18.0%
- Total debt
- −1.59%
Quarter to September 2026, against a year earlier
Follow XRAY
Alert me
DENTSPLY SIRONA Inc. (XRAY) Total debt
DENTSPLY SIRONA Inc.'s total debt at the end of fiscal 2025 was $2.0B, up 27.0% from $1.6B in fiscal 2024. At the end of the quarter to 30 September 2026 it was $2.0B. Over the past ten years it has ranged from $1.1B (fiscal 2015) to $2.0B (fiscal 2025) — the current reading is the highest in ten years. DENTSPLY SIRONA Inc. ranks 9th of 50 Medical Instruments & Supplies companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $2.0B | 27.05% |
| FY2024 | $1.6B | (11.69%) |
| FY2023 | $1.8B | (1.64%) |
| FY2022 | $1.8B | (4.55%) |
| FY2021 | $1.9B | (3.29%) |
| FY2020 | $2.0B | 38.03% |
| FY2019 | $1.4B | (8.43%) |
| FY2018 | $1.6B | (2.90%) |
| FY2017 | $1.6B | 6.65% |
| FY2016 | $1.5B | 32.44% |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $2.0B | (0.55%) |
| Jun 2026 | $2.0B | (0.50%) |
| Mar 2026 | $2.0B | (0.45%) |
| Dec 2025 | $2.0B | (0.10%) |
| 43 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| XRAY DENTSPLY SIRONA Inc. | $2.0B |
| STVN Stevanato Group S.p.A. compare | $545.0M |
| WRBY Warby Parker Inc. compare | $170.2M |
| LMAT LeMaitre Vascular, Inc. compare | $169.3M |
| KMTS Kestra Medical Technologies, Ltd. compare | $72.5M |
| AZTA Azenta, Inc. compare | $72.0M |
| ATRC AtriCure, Inc. compare | $61.0M |
| STAA STAAR Surgical Company compare | $31.2M |
| PLSE Pulse Biosciences, Inc compare | $9.4M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on XRAY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement